PCI 0123

Known as: PCI-0123 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2000
01219962000

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
We have investigated the pharmacokinetics (PK) of Lutetium Texaphyrin (Lu-Tex), a second-generation photosensitizer, in the… (More)
Is this relevant?
1999
1999
BACKGROUND AND OBJECTIVE New photosensitizers proposed for photodynamic therapy (PDT) treatment of tumors need to be evaluated in… (More)
Is this relevant?
1998
1998
Photodynamic therapy (PDT) of pigmented melanoma has generally been unsuccessful because of insufficient light penetration in… (More)
Is this relevant?
1997
1997
Lutetium texaphyrin (PCI-0123) is a pure, water-soluble photodynamic therapy (PDT) agent that is activated by tissue-penetrating… (More)
Is this relevant?
1996
1996
Lutetium texaphyrin, PCI-0123, is a pure, water-soluble photosensitizer with a large broad absorption band centered at 732 nm… (More)
Is this relevant?
1996
1996
Cancer and cardiovascular disease are the leading causes of death in the western world. Photodynamic therapy (PDT) has… (More)
Is this relevant?